article thumbnail

Big data offers promise of better groundwater management in California

Scienmag

Analysis of 200,000 groundwater samples reveals major mismatch in California groundwater data To ensure that California’s groundwater is sustainably managed in the future and over the long-term, current state definitions of what constitutes groundwater may need to be revised, according to research published this week in PNAS.

article thumbnail

PMN Innovation Summit 2021

Pharma Marketing Network

Licensed Clinical Psychologist, Clinical Director, Virtual Counselor/College Telehealth. The term can be used to describe several different technology-related healthcare applications that includes categories like EHR, mHealth, wearables Telehealth, big data, apps, and personalized medicine. Reena Kolar , Ph.D,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PMN Innovation Summit 2021

Pharma Marketing Network

Licensed Clinical Psychologist, Clinical Director, Virtual Counselor/College Telehealth. The term can be used to describe several different technology-related healthcare applications that includes categories like EHR, mHealth, wearables Telehealth, big data, apps, and personalized medicine. Reena Kolar , Ph.D,

article thumbnail

Making its mark: AI in drug discovery 

Drug Discovery World

This comment followed the announcement by AI-driven pharma-tech company Exscientia that Bristol Myers Squibb had chosen to in-license its immune-modulating drug candidate. . This platform is powered by patient molecular data in autoimmune diseases and artificial intelligence network science-based algorithms.

Drugs 52
article thumbnail

Rare diseases, repurposing and the role of AI

pharmaphorum

These might be licensed drugs that could hold potential for a patent extension, or drugs which failed efficacy trials for an intended indication. In the quest to repurpose a drug for a rare condition, there is a need to look at any and all available data.

article thumbnail

Digital biomarkers in pharma: Q&A with Medidata’s Mark Matson 

Drug Discovery World

Bringing the digital biomarker experts from MC10 together with a team of big data architects at Medidata allowed us to create a scalable sensor platform and speed up the development of digital biomarkers by normalising the data into a common data model where downstream analysis is based on a common data structure.

article thumbnail

STAT+: In Theranos’s backyard, a health tech leader takes another crack at better blood tests

STAT News

PALO ALTO — Step outside the quiet Stanford Medicine building where geneticist and prominent big data expert Mike Snyder has spent years poring over tiny samples of blood, and you can just see the outline of 1701 Page Mill Road, one of the original offices of Theranos. Continue to STAT+ to read the full story…

Big Data 119